Alliant Pharmaceuticals
2004
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Producer of pediatric pharmaceutical products. The company is engaged in acquiring, developing and commercializing proprietary products for the allergy and immunology, psychiatry, neurology, dermatology, urology, infectious diseases, pediatric and pediatric specialty markets.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
- 333 North Point Center East
- Suite 250
- Alpharetta, GA 30022
- United States
Alliant Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Alliant Pharmaceuticals‘s full profile, request access.
Request full access to PitchBookAlliant Pharmaceuticals Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Michael Stresser | Chief Financial Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »